Author

A. Nicholls

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

G. J. Hannon· 2 shared A. Hobeika· 1 shared C. A. Rebbeck· 1 shared CRUK IMAXT Grand Challenge Team· 1 shared D. Bressan· 1 shared E. Rozhkova· 1 shared H. Geiger· 1 shared H. K. Lyerly· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

G. J. Hannon

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Creating a 'Timeline' of ductal carcinoma in situ to identify processes and biomarkers for progression towards invasive ductal carcinoma

C. A. Rebbeck, J. Xian, S. Bornelov, J. Geradts, A. Hobeika, H. Geiger, J. F. Alvarez, E. Rozhkova, A. Nicholls, N. Robine, H. K. Lyerly, G. J. Hannon

The paper generates a disease progression timeline for DCIS using gene expression data to identify early processes and biomarkers associated with progression to invasive breast cancer.

bioRxiv · Mar 1, 2022Cancer Biology

Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies.

S. A. Wild, I. G. Cannell, K. Kania, A. Nicholls, D. Bressan, CRUK IMAXT Grand Challenge Team, G. J. Hannon, K. Sawicka

The paper uses clonal transcriptomics to identify mechanisms of chemoresistance in TNBC and suggests asparagine deprivation as a potential combination therapy.

bioRxiv · Dec 9, 2021Cancer Biology